Visual outcomes following intraophthalmic artery melphalan for retinoblastoma: summary of visual acuity results
| Feature | Number (%) n=12 |
|---|---|
| Age appropriate visual acuity before IAM | |
| Normal | 12 (100%) |
| Below normal | 0 (0%) |
| Age appropriate final visual acuity after IAM | |
| Normal | 7 (58%) |
| Below normal | 5 (42%) |
| Eyes with any reduction of visual acuity | 5 (42%) |
| Eyes losing greater than 6 Snellen lines | 2 (17%) |
| Any visual loss in relation to tumour quadrant relative to optic disc | |
| Superior | 0/2 |
| Nasal | 0/2 |
| Temporal | 4/6 |
| Inferior | 1/2 |
| Any visual loss in relation to tumour distance to fovea | |
| 0–0.2 mm | 1/3 |
| 0.2–0.5 mm | 1/2 |
| 0.5–1.0 mm | 1/1 |
| 1.0–1.5 mm | 0 |
| 1.5–3.0 mm | 0/2 |
| >3.0 mm | 2/4 |
| Reason for visual loss | |
| Choroidal Ischaemia | |
| Diffuse | 2 (40%) |
| Sectoral | 2 (40%) |
| Retinal detachment | |
| Diffuse | 1 (20%) |
| Sectoral | 0 (0%) |
IAM, intra-arterial melphalan.